Moreover, Ohata et al. demonstrated that caffeine, as well as a specific A2AR antagonist, ZM241385, increased the ability of tumor antigen-specific CD8+ T lymphocytes to destroy implanted tumor cells [166]. Here, ADORA2A is linked to neoplasm.